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Table 1 of this paper published in the January 2015 issue contains several errors. The Derp1 peptide comes from the Der p1 protein of
Dermatophagoides pteronyssinus not the Der f1 protein of Dermatophagoides farinae. The sequence of the MOG peptide in the I-Ab
tetramer used in the study was GWYRSPFSRVV not GWYRSPFSRVVVHLY. Themost likely 9 amino acid core register for the OVA2C
peptide in the I-Ab tetramer used in the study is VHAAHAEIN not AVHAAHAEI, which is the secondmost likely. Themost likely register
has a different number of predicted self peptide homologs than the second most likely one, which changed the x axis value for
the OVA2C peptide in Figure 4G. However, neither the level of statistical significance of the correlation between the number of
self peptide homologs and the number of naive cells specific for foreign peptides shown in Figure 4G nor the conclusion that
‘‘TCR cross-reactivity on self-peptide homologs plays some role in determining the size of MHCII-bound foreign peptide-specific
CD4+ T cell populations’’ were changed. Thus, none of these errors affect any of the conclusions of the paper. The authors deeply
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